© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Hydroxyzine Hydrochloride stands out as a synthetic organic compound, widely recognized in both medical and industrial contexts. Inside a laboratory, you’ll find this material as a white, odorless crystalline powder, often labeled under the HS Code 29333990 for import and export. Its chemical formula, C21H27ClN2O2, underscores its molecular complexity, reflecting a molar mass of 374.91 g/mol. The structure consists of a piperazine ring and a phenylmethyl group, elements that provide its distinctive pharmacological activities. Not just a laboratory staple, Hydroxyzine Hydrochloride performs as an effective antihistamine and anxiolytic, often utilized to calm allergies and itchiness, as well as tension and anxiety.
Looking at Hydroxyzine Hydrochloride, you get a fine, white or off-white solid, generally offered in powder or crystalline form. Sometimes, it appears as flakes, though rarely processed as pearls or liquid solutions outside pharmaceutical compounding. One striking detail is its density, scaling near 1.32 g/cm³ at room temperature, which informs how it behaves in storage and during pharmaceutical manufacturing. Its melting point lands firmly at 190–194°C, hinting that the material keeps its stable form under typical handling conditions. Solubility marks another critical property; Hydroxyzine Hydrochloride dissolves easily in water and ethanol, an important trait for those blending it into medicinal suspensions or tablets. The solution, clear with a faintly bitter taste, must be measured and administered accurately by health professionals to avoid accidental overdose or harmful reactions.
Hydroxyzine Hydrochloride works beyond its identity as a finished drug; countless labs around the world depend on its raw chemical form. Manufacturers tap its anti-allergic and sedative properties to create tablets, capsules, oral solutions, and injectable medications. In raw material procurement, strict specifications help guarantee safety and effectiveness. These include high purity benchmarks—often above 98%—minimal heavy metal traces, and zero detectable impurities. Consistent particle size, powder texture, and crystal clarity become practical concerns because they influence subsequent mixing, blending, and stability of final pharmaceutical products. Without such vigilance, the material might unpredictably alter the shelf-life or potency of an entire drug batch.
Handling Hydroxyzine Hydrochloride demands caution, especially in bulk. Its molecular build delivers precise therapeutic effects at small doses, but contact or inhalation of raw powder may cause irritation or worse in unprotected individuals. People inside pharmaceutical labs often wear gloves, goggles, and masks—not just following protocol—to avoid accidental skin contact or respiratory exposure. Its dust, though faint, carries a risk of allergic reactions or respiratory distress. Hydroxyzine Hydrochloride stores best in cool, dry environments, sealed in airtight containers. People must never mistake it for a benign compound; in higher concentrations or when mishandled, it causes drowsiness, confusion, and in rare cases, cardiac complications. Material safety data sheets classify it as potentially hazardous, highlighting risks like eye irritation, skin sensitization, and environmental toxicity. It’s irresponsible to pour waste solutions down the drain or allow powder to contaminate public spaces. Professional disposal procedures call for coordination with chemical waste specialists, not only for regulatory compliance but for the broader health of workers and the community.
Precise, transparent product description helps buyers, regulators, and users avoid mistakes that can jeopardize safety or financial investment. I recall a case where a mislabeled raw material shipment contained a slightly higher moisture level than specified. Production came to a standstill. The team spent hours tracking down the culprit, and the entire shipment was rejected. That taught us a sharp lesson: integrity in reporting specifications—like density, color, melting point, and grade—translates directly into human and economic well-being. Health authorities worldwide regularly inspect consignment and material data sheets for compliance, requiring certificates of analysis, manufacturing process transparency, and chain-of-custody reporting. Honest specification protects everyone in the value chain, and in health-related industries, a misstep costs more than just money.
Every batch of Hydroxyzine Hydrochloride undergoes rigorous testing to confirm its molecular integrity. Spectral tests (IR, NMR, and MS) check that the chemical structure matches pharmacopoeial standards. Any deviation, even on the microscopic level, can introduce harmful by-products or weaken therapeutic action. Chemists and quality assurance specialists look for typical peaks and shifts that help verify purity and identify contaminants. In my early lab days, I learned to respect this process because a single spectral anomaly brought a huge project to a halt, requiring weeks to resolve. Reliable structure means reliable product—critical when the end-user trusts the label to guide medical care.
On the industrial side, suppliers must maintain traceable records of raw material origin, manufacturing dates, and lot numbers. Training for laboratory workers and warehouse staff substantially reduces workplace accidents and material mishandling. Governments, companies, and scientific organizations work together to toughen regulations, ensure worker safety, and educate communities about responsible chemical handling. Several countries adopt the Globally Harmonized System for chemical labeling and hazard communication as a rule rather than an option. Digital inventory management and barcoding minimize the risk of confusion or cross-contamination. Every participant—from material scientists to shipping clerks—plays a part in keeping Hydroxyzine Hydrochloride safe, effective, and ready for use.
